Iceni Diagnostics

Iceni Diagnostics is a UK-based biotechnology company specializing in the development of glycan-based diagnostics and therapeutics for infectious diseases. Spun out from the John Innes Centre and the University of East Anglia, the company leverages its proprietary Host-Pathogen Glycan Recognition (HPGR) platform to create rapid, point-of-care tests that identify pathogens based on their sugar-binding signatures. Their technology utilizes glycan-functionalized gold nanoparticles to provide results in under 15 minutes without the need for complex laboratory equipment or specialized training. Key focus areas include respiratory viruses like COVID-19 and influenza, as well as gastrointestinal pathogens such as norovirus. Iceni's approach offers a robust alternative to traditional antibody-based diagnostics, providing high specificity and the ability to distinguish between different viral strains and variants.